Clinical Trial Update: Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1% [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics, pharmacodynamics, and safety of testosterone gel 1% in postmenopausal women has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• TESTOSTERONE GEL, 1% (TESTOSTERONE GEL, 1%)

Snippet

Sponsor: Biolab Sanus Farmaceutica | Conditions: Post-menopausal Period | Phase 1 | Status: WITHDRAWN